A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults

计划入组 644 人 · 首次发布于 2024 年 2 月 1 日

Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines

计划入组 400 人 · 首次发布于 2023 年 8 月 2 日

A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals

计划入组 1,051 人 · 首次发布于 2023 年 8 月 18 日

SCB-2023B

CoTend-BXBB

Recombinant COVID-19 XBB.1.5 Vaccine(Adenovirus type 5 vector)

CanSino Biologics Inc.

China

MILITARY HOSPITAL 175

Vietnam

BBB-Therapeutics B.V.

Netherlands

FDA Warns Evusheld May Be Ineffective Against COVID-19 Subvariant XBB.1.5

Novel Trivalent COVID-19 Vaccine Shows Robust Cross-Protection Against XBB Variants

FDA Approves Updated COVID-19 Vaccines from Pfizer and Moderna Targeting XBB.1.5 Omicron Variant